Last reviewed · How we verify
NCT03293628
Comparing Two Techniques of Haemostasis After Cervical Conization
Phase 2 trial testing Vaginal Packing in Cervical Intraepithelial Neoplasia in 100 participants. Completed in 30 January 2016.
30 June 2015
Quick facts
| Lead sponsor | Barretos Cancer Hospital |
|---|---|
| Phase | Phase 2 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 1 October 2014 |
| Primary completion | 30 June 2015 |
| Estimated completion | 30 January 2016 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Vaginal Packing
Conditions studied
- Cervical Intraepithelial Neoplasia — all drugs for Cervical Intraepithelial Neoplasia →
- Cervix Neoplasm — all drugs for Cervix Neoplasm →
Sponsor
Barretos Cancer Hospital
Who can join
Adults 19 to 68, female only, with Cervical Intraepithelial Neoplasia or Cervix Neoplasm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The LEEP conization is commonly used for cervical pathologies treatment. The techniques for hemostasis usually used are: cautery, Monsel's solution and vaginal pack. Actually, there is no consensus about the best technique and there is not much information that validates the use of some of that. To compare the use or not of vaginal pack as methods of hemostasis after LEEP conization for management of cervical lesions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03293628
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cervical Intraepithelial Neoplasia
Currently open trials in the same condition.
- NCT07275333 — Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine · NA · recruiting
- NCT06815939 — Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer · NA · recruiting
- NCT06810427 — A Novel, Low-Cost, Handheld 3D Imaging System for Improved Screening for Cervical Neoplasia in Resource-Limited Settings · NA · active not recruiting
- NCT06191133 — Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma · Phase 1 · recruiting
- NCT06243666 — Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls · active not recruiting
Other Barretos Cancer Hospital trials
Trials by the same sponsor.
- NCT06356012 — Clinical Outcome and Biomarkers for Predicting Immunological Response in Patients Treated with Imiquimod · Phase 4 · recruiting
- NCT05491395 — Hypofractionated Radiotherapy in Breast Cancer Patients With Prosthetic Reconstruction · NA · recruiting
- NCT05078528 — Low-cost Imaging Technology for Global Prevention of Cervical Cancer · NA · recruiting
- NCT06801405 — Antibiotic Prophylaxis in Percutaneous Nephrostomy Placements and Replacements for Malignant Urinary Tract Obstruction · completed
- NCT04025112 — Randomized Clinical Trial Comparing Rehabilitation Robotic Versus Conventional After Breast Cancer Surgery · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03293628 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Barretos Cancer Hospital
- Last refreshed: 28 September 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03293628.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing